Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Cash & Equivalents (2024 - 2026)

Updated

Kardigan (KARD) reported Cash & Equivalents of $78.89 million for Q3 2026, down 79.5% from the prior quarter.

Analysis

Kardigan (KARD) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Kardigan posted Cash & Equivalents of $108.99 million, up 120.6% from FY2024.

  • By year, Cash & Equivalents came in at $49.4 million in FY2024.
  • The Q3 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q4 2024.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $384.01 million (Q2 2026), $81.55 million (Q1 2026) and $108.99 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 16.91 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 10.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 400.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.82 Bn
10 Kardigan 1.29 Bn -398.44 Mn - 78.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 78.89 Mn
Jun 30, 2026 384.01 Mn
Mar 31, 2026 81.55 Mn
Dec 31, 2025 108.99 Mn
Jun 30, 2025 90.12 Mn
Dec 31, 2024 49.40 Mn
API Access

Kardigan Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KARD&period=max&api_key=YOUR_API_KEY